Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

[1]  M. Wu,et al.  Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. , 1984, Biochemical and biophysical research communications.

[2]  C. Hinds,et al.  Effects of intravascular volume expansion on the cardiovascular response to naloxone in a canine model of severe endotoxin shock , 1984, British journal of pharmacology.

[3]  J. C. Ludwig,et al.  High performance liquid chromatography of platelet-activating factors. , 1984, Journal of lipid research.

[4]  L. McManus,et al.  Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. , 1984, Circulation research.

[5]  F. Snyder,et al.  A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. , 1984, Biochemical and biophysical research communications.

[6]  J. Hildebrandt,et al.  Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. , 1983, The Journal of clinical investigation.

[7]  R. Bone,et al.  Ibuprofen in canine endotoxin shock. , 1982, The Journal of clinical investigation.

[8]  J. B. Martin,et al.  Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo. , 1982, Science.

[9]  W. Zapol,et al.  Acute Pulmonary Hypertension and Lung Thromboxane Release after Endotoxin Infusion in Normal and Leukopenic Sheep , 1982, Circulation research.

[10]  J. Egido,et al.  Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. , 1982, Immunopharmacology.

[11]  W. Mitch,et al.  PRESSOR EFFECT OF NALOXONE IN SEPTIC SHOCK , 1981, The Lancet.

[12]  R. Farr,et al.  Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). , 1980, Clinical immunology and immunopathology.

[13]  F. Snyder,et al.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.

[14]  D. Hanahan,et al.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. , 1979, Journal of immunology.

[15]  R. Ulevitch,et al.  The effects of bacterial endotoxins on host mediation systems. A review. , 1978, The American journal of pathology.

[16]  J. Holaday,et al.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock , 1978, Nature.

[17]  M. Laubie,et al.  Central cardiovascular effects of morphinomimetic peptides in dogs. , 1977, European journal of pharmacology.

[18]  J. Fletcher,et al.  MODIFICATION, BY ASPIRIN AND INDOMETHACIN, OF THE HAEMODYNAMIC AND PROSTAGLANDIN RELEASING EFFECTS OF E. coli ENDOTOXIN IN THE DOG , 1977, British journal of pharmacology.

[19]  J. Parratt,et al.  THE POSSIBLE ROLES OF HISTAMINE, 5‐HYDROXYTRYPTAMINE AND PROSTAGLANDIN F2α AS MEDIATORS OF THE ACUTE PULMONARY EFFECTS OF ENDOTOXIN , 1977, British journal of pharmacology.

[20]  W. Jubiz,et al.  Endotoxin-induced prostaglandin E and F release in dogs. , 1975, The American journal of physiology.

[21]  P. Henson,et al.  LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS THE ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR , 1972 .

[22]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.